论文部分内容阅读
目的研究观察对慢性阻塞性肺炎患者采用多索茶碱治疗的临床疗效。方法选择60例慢性阻塞性肺炎患者,将其随机分为治疗组与对照组,每组各30例。对两组患者采用不同治疗方法,并进行疗效比较。结果治疗组患者的总显效率96.67%显著高于对照组的总显效率53.33%,差异显著具有统计学意义(P<0.05)。治疗组患者在治疗后的PCO2明显低于治疗前,而升高的幅度与对照组比较,差异显著具有统计学意义(P<0.05);治疗组患者在治疗后的PO2明显高于治疗前,而降低的幅度与对照组比较,差异显著具有统计学意义(P<0.05)。结论采用多索茶碱治疗慢性阻塞性肺炎,有较好的临床疗效,值得临床推广。
Objective To observe the clinical efficacy of doxofylline in patients with chronic obstructive pulmonary disease. Methods Sixty patients with chronic obstructive pulmonary disease were selected and randomly divided into treatment group and control group with 30 cases in each group. Two groups of patients with different treatment methods, and the efficacy comparison. Results The total effective rate of the treatment group was significantly higher than that of the control group (96.67%, 53.33%), the difference was statistically significant (P <0.05). The PCO2 of the treatment group was significantly lower than that of the control group before treatment, while the amplitude of the increase was significantly different from that of the control group (P <0.05). The PO2 of the treatment group was significantly higher than that before treatment The magnitude of decrease was significantly different from the control group (P <0.05). Conclusion Doxofylline in the treatment of chronic obstructive pulmonary disease has a good clinical efficacy, worthy of clinical promotion.